Jefferies Financial Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Jefferies Financial Group's DNTH Position: Q3 2026 in Review
Jefferies Financial Group sold out of Dianthus Therapeutics (DNTH) in Q3 2026, closing a stake of 5,886 shares — an estimated $574K sold.
Jefferies Financial Group first reported a position in DNTH in Q3 2023 and held it in 5 quarters. The position peaked at $17M in Q1 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Jefferies Financial Group reported no remaining Dianthus Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jefferies Financial Group sold 5,886 Dianthus Therapeutics shares in Q3 2026, an estimated $574K.
- Jefferies Financial Group first reported a position in Dianthus Therapeutics in Q3 2023 and held it in 5 quarters.
- Jefferies Financial Group's Dianthus Therapeutics position peaked at $17M in Q1 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.